Alzheimer's disease and its treatment costs: case study in the Czech Republic

QR Code

Alzheimer's disease and its treatment costs: case study in the Czech Republic

Hana Mohelska,1 Petra Maresova,2 Martin Valis,3 Kamil Kuca4,5 1Department of Management, 2Department of Economy, Faculty of Informatics and Management, University of Hradec Králové, 3Department of Neurology, Charles University in Prague, Faculty of Medicine in Hradec Kr&aa...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Mohelska H, Maresova P, Valis M, Kuca K
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2015
Sujets:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/d56d38f9115b403aa3ad9a9950902d58
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer&#39;s disease in the Netherlands
par: Hoogveldt B, et autres
Publié: (2011)

Galantamine treatment in Alzheimer&#39;s disease: response and long-term outcome in a routine clinical setting
par: Wallin &Aring;K, et autres
Publié: (2011)

Domperidone effective in preventing rivastigmine-related gastrointestinal disturbances in patients with Alzheimer's disease
par: Kano O, et autres
Publié: (2013)

Retrospective case studies of the efficacy of caprylic triglyceride in mild-to-moderate Alzheimer's disease
par: Maynard SD, et autres
Publié: (2013)

Exploring assistive technology as a potential beneficial intervention tool for people with Alzheimer’s disease – a systematic review
par: Klimova B, et autres
Publié: (2018)

Retrospective cohort study of the efficacy of caprylic triglyceride in patients with mild-to-moderate Alzheimer's disease
par: Maynard SD, et autres
Publié: (2013)

Violence in persons with and without psychosis in the Czech Republic: risk and protective factors
par: Černý M, et autres
Publié: (2018)

Minimally invasive biomarker confirms glial activation present in Alzheimer&#39;s disease: a preliminary study
par: Tran T, et autres
Publié: (2011)

Decreased white matter integrity before the onset of delusions in patients with Alzheimer&#39;s disease: diffusion tensor imaging
par: Nakaaki S, et autres
Publié: (2012)

Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia
par: Masopust J, et autres
Publié: (2015)

Prediction of population with Alzheimer's disease in the European Union using a system dynamics model
par: Tomaskova H, et autres
Publié: (2016)

Two cases of Alzheimer&#39;s disease showing deterioration of behavioral and psychological symptoms of dementia induced by switching from rivastigmine to donepezil
par: Kimura T, et autres
Publié: (2012)

The cost reduction in hospitalization associated with paliperidone palmitate in the People’s Republic of China, Korea, and Malaysia
par: Chiou CF, et autres
Publié: (2015)

Editor&#39;s choice
par: Pinder RM
Publié: (2012)

Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? A case series of 39 patients
par: Yoshimura B, et autres
Publié: (2013)

Health care resource use and direct medical costs for patients with schizophrenia in Tianjin, People’s Republic of China
par: Wu J, et autres
Publié: (2015)

Optimal treatment of Alzheimer’s disease psychosis: challenges and solutions
par: Koppel J, et autres
Publié: (2014)

Early stages of pediatric bipolar disorder: retrospective analysis of a Czech inpatient sample
par: Goetz M, et autres
Publié: (2015)

Gene–Environment Interactions in Major Mental Disorders in the Czech Republic
par: Latalova K, et autres
Publié: (2020)

Review: management of Parkinson&#39;s disease
par: Pedrosa DJ, et autres
Publié: (2013)

The emerging role of bexarotene in the treatment of Alzheimer’s disease: current evidence
par: Tousi B
Publié: (2015)

Assistive technologies for managing language disorders in dementia
par: Klimova B, et autres
Publié: (2016)

Acupuncture in migraine prophylaxis in Czech patients: an open-label randomized controlled trial
par: Musil F, et autres
Publié: (2018)

Parkinson's disease managing reversible neurodegeneration [Corrigendum]
par: Hinz M, et autres
Publié: (2016)

Adjunctive therapy in Parkinson&#39;s disease: the role of rasagiline
par: Gaines KD, et autres
Publié: (2012)

Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer&rsquo;s disease in daily practice
par: Seibert J, et autres
Publié: (2012)

The impact of nonmotor symptoms on quality of life in patients with Parkinson's disease in Taiwan
par: Liu WM, et autres
Publié: (2015)

A case of early onset Parkinson's disease after major stress
par: Zou K, et autres
Publié: (2013)

Do neurologists in Germany adhere to the national Parkinson&#39;s disease guideline?
par: Sabrina Schr&ouml;der, et autres
Publié: (2011)

Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer&rsquo;s disease
par: Umamon Puangthong, et autres
Publié: (2009)

A review of the potential therapeutic role of statins in the treatment of Alzheimer&rsquo;s disease: current research and opinion
par: Mitchell AJ, et autres
Publié: (2013)

The effect of cognitive status and visuospatial performance on affective theory of mind in Parkinson's disease
par: McKinlay A, et autres
Publié: (2013)

Neuroinflammation in Alzheimer’s disease
par: Zhang FJ, et autres
Publié: (2015)

Profile of minocycline and its potential in the treatment of schizophrenia
par: Zhang L, et autres
Publié: (2014)

Profile of brivaracetam and its potential in the treatment of epilepsy
par: Ferlazzo E, et autres
Publié: (2015)

Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer&rsquo;s disease receiving donepezil
par: Kano O, et autres
Publié: (2013)

The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis
par: Kishi T, et autres
Publié: (2017)

The cost of schizophrenia in Japan
par: Sado M, et autres
Publié: (2013)

The societal costs of insomnia
par: Alan G Wade
Publié: (2010)

Magnetic resonance spectroscopy in Alzheimer’s disease
par: Graff-Radford J, et autres
Publié: (2013)